OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, will host its latest State of the Science Summit™ on Lung Cancer Thursday, Oct. 17, from 5-9 p.m. at the Wyndham Grand Chicago Riverfront in Illinois. The chair for the summit will be Jyoti D. Patel, M.D., professor of medicine and director of thoracic oncology at University of Chicago Medicine.This interactive and educational meeting will analyze and discuss novel treatments for patients with lung cancer. The expert presenters will explore a wide variety of informative topics surrounding lung cancer, such as pathologic considerations in non-small cell lung cancer (NSCLC); the role of liquid biopsy/tissue testing; the new standard of care for stage 3 NSCLC; new immunotherapy combinations in stage 4 nonsquamous NSCLC; updates in immunotherapy in stage 4 squamous NSCLC, EGFR-positive NSCLC, ALK-positive and ROS1 NSCLC; targetable biomarkers in NSCLC; and updates in the management of small cell lung cancer. The presenters will also engage in a peer exchange and address audience questions.
State of the Science Summit™ is a premier conference series hosted by OncLive® that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.